Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Schiffman

Showing results (61-70 of 498) with videos related to

Pageof 50
Sort By:
Journal of Lower Genital Tract Disease|December 29, 2007
Spectroscopic imaging as triage test for cervical diseaseJulia C Gage, Mahboobeh Safaeian, Jose Jeronimo, et al.
Cancer|November 5, 2008
Predicting the effect of successful human papillomavirus vaccination on existing cervical cancer prevention programs in the United StatesPhilip E Castle, Diane Solomon, Debbie Saslow, et al.
Journal of the National Cancer Institute|July 21, 2005
Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalitiesPhilip E Castle, Diane Solomon, Mark Schiffman, et al.
Obstetrics and Gynecology|December 24, 2008
Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2Philip E Castle, Mark Schiffman, Cosette M Wheeler, et al.
Gynecologic Oncology|December 5, 2008
Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-scienceNicolas Wentzensen, Mark E Sherman, Mark Schiffman, et al.
American Journal of Clinical Pathology|August 21, 2012
A descriptive analysis of prevalent vs incident cervical intraepithelial neoplasia grade 3 following minor cytologic abnormalitiesPhilip E Castle, Patti E Gravitt, Nicolas Wentzensen, et al.
Vaccine|September 5, 2006
Chapter 5: Updating the natural history of HPV and anogenital cancerAnna-Barbara Moscicki, Mark Schiffman, Susanne Kjaer, et al.
American Journal of Obstetrics and Gynecology|August 8, 2006
Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS)Joan L Walker, Sophia S Wang, Mark Schiffman, et al.
Journal of Lower Genital Tract Disease|June 25, 2009
The accuracy of colposcopic grading for detection of high-grade cervical intraepithelial neoplasiaL Stewart Massad, Jose Jeronimo, Hormuzd A Katki, et al.
Cancer|September 5, 2006
Comparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesionRosemary E Zuna, Sophia S Wang, Mark Schiffman, et al.
Pageof 50

Showing results (61-70 of 498) with videos related to

Sort By:
Pageof 50
Journal of Lower Genital Tract Disease|December 29, 2007
Spectroscopic imaging as triage test for cervical diseaseJulia C Gage, Mahboobeh Safaeian, Jose Jeronimo, et al.
Cancer|November 5, 2008
Predicting the effect of successful human papillomavirus vaccination on existing cervical cancer prevention programs in the United StatesPhilip E Castle, Diane Solomon, Debbie Saslow, et al.
Journal of the National Cancer Institute|July 21, 2005
Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalitiesPhilip E Castle, Diane Solomon, Mark Schiffman, et al.
Obstetrics and Gynecology|December 24, 2008
Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2Philip E Castle, Mark Schiffman, Cosette M Wheeler, et al.
Gynecologic Oncology|December 5, 2008
Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-scienceNicolas Wentzensen, Mark E Sherman, Mark Schiffman, et al.
American Journal of Clinical Pathology|August 21, 2012
A descriptive analysis of prevalent vs incident cervical intraepithelial neoplasia grade 3 following minor cytologic abnormalitiesPhilip E Castle, Patti E Gravitt, Nicolas Wentzensen, et al.
Vaccine|September 5, 2006
Chapter 5: Updating the natural history of HPV and anogenital cancerAnna-Barbara Moscicki, Mark Schiffman, Susanne Kjaer, et al.
American Journal of Obstetrics and Gynecology|August 8, 2006
Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS)Joan L Walker, Sophia S Wang, Mark Schiffman, et al.
Journal of Lower Genital Tract Disease|June 25, 2009
The accuracy of colposcopic grading for detection of high-grade cervical intraepithelial neoplasiaL Stewart Massad, Jose Jeronimo, Hormuzd A Katki, et al.
Cancer|September 5, 2006
Comparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesionRosemary E Zuna, Sophia S Wang, Mark Schiffman, et al.
Pageof 50